Stéphanie Cailloux is the Co-Founder and General Director at INVERS, currently leading efforts in innovative drug development. Previously, Stéphanie held various managerial positions, including Business Manager at Eurobiobiz and BUSI Business Incubator, as well as Administrative and Financial Manager at Nucleica and European Program Manager at Spinelix. Stéphanie also contributed to INNOPAIN as Deputy Director from 2015 to 2019 and served on its Strategic Committee from 2019 to 2021. Stéphanie earned a Master's degree in Biology from Université Blaise Pascal (Clermont Ferrand II) in 1999.
This person is not in the org chart
This person is not in any teams
This person is not in any offices